World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
19786
World Ranking
4817
National Ranking
356

Chemistry

D-Index
66
Citations
15509
World Ranking
7276
National Ranking
521

Stefan Laufer publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Stefan Laufer sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 453 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Stefan Laufer D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stefan Laufer sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Stefan Laufer is affiliated with the University of Tübingen in Germany and has contributed extensively to the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their research portfolio includes a strong focus on Molecular Biology, Organic Chemistry, Computational Theory and Mathematics, Oncology, and Pharmacology.

The scientist's work covers a variety of topics, including:

  • Computational Drug Discovery Methods
  • Melanoma and MAPK Pathways
  • Synthesis and biological activity
  • Click Chemistry and Applications
  • Cancer Mechanisms and Therapy
  • Cholinesterase and Neurodegenerative Diseases
  • SARS-CoV-2 and COVID-19 Research

Stefan Laufer has published research frequently in several notable venues, such as:

  • Journal of Medicinal Chemistry
  • Archiv der Pharmazie
  • Zenodo (CERN European Organization for Nuclear Research)
  • International Journal of Molecular Sciences
  • European Journal of Medicinal Chemistry

Their recent notable publications include:

  • "Candidate drugs against SARS-CoV-2 and COVID-19," 2020, Pharmacological Research
  • "An updated patent review of p38 MAP kinase inhibitors (2014-2019)," 2020, Expert Opinion on Therapeutic Patents
  • "Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination," 2022, Journal of Medicinal Chemistry
  • "A Highly Selective In Vitro JNK3 Inhibitor, FMU200, Restores Mitochondrial Membrane Potential and Reduces Oxidative Stress and Apoptosis in SH-SY5Y Cells," 2021, International Journal of Molecular Sciences
  • "Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy," 2021, Journal of Medicinal Chemistry

Stefan Laufer collaborates regularly with other researchers, including:

  • Tatu Pantsar
  • Thales Kronenberger
  • Thanigaimalai Pillaiyar
  • Stefan Knapp
  • Michael Förster

Best Publications

  • Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

    Matthias Gehringer;Stefan A. Laufer

  • Candidate drugs against SARS-CoV-2 and COVID-19.

    Dwight L. McKee;Ariane Sternberg;Ulrike Stange;Stefan Laufer

  • Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation

    Oliver Borst;Britta Walker;Patrick Münzer;Antonella Russo

  • Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts.

    M. Fronza;B. Heinzmann;M. Hamburger;S. Laufer

  • Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.

    Sarah Taves;Temugin Berta;Da-Lu Liu;Sophie Gan

  • In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer

    Ramona Rudalska;Daniel Dauch;Thomas Longerich;Katherine McJunkin

  • A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

    Daniel Dauch;Ramona Rudalska;Giacomo Cossa;Jean-Charles Nault

  • The Cysteinome of Protein Kinases as a Target in Drug Development.

    Apirat Chaikuad;Apirat Chaikuad;Pierre Koch;Stefan A. Laufer;Stefan Knapp

  • Tetrasubstituted imidazole inhibitors of cytokine release: probing substituents in the N-1 position.

    Stefan A. Laufer;Werner Zimmermann;Kathrin J. Ruff

  • Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

    Fabio Celotti;Stefan Laufer

  • Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI

    Raynauld Jp;Martel-Pelletier J;Bias P;Laufer S

  • The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K

    Jean-Pierre Pelletier;Christelle Boileau;Julie Brunet;Martin Boily

  • Biological studies on Brazilian plants used in wound healing

    C. Schmidt;M. Fronza;M. Goettert;F. Geller

  • Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1

    Andreas Koeberle;Ulf Siemoneit;Ulrike Bühring;Hinnak Northoff

  • PGE(2) in the regulation of programmed erythrocyte death.

    P A Lang;D S Kempe;S Myssina;V Tanneur

  • New Approaches to the Treatment of Inflammatory Disorders Small Molecule inhibitors of p38 MAP Kinase

    Christian Peifer;Gerd Wagner;Stefan Laufer

  • (6,7-Diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase.

    Stefan A. Laufer;Jan Augustin;Gerd Dannhardt;Werner Kiefer

  • Progress towards a public chemogenomic set for protein kinases and a call for contributions

    David H. Drewry;Carrow I. Wells;David M. Andrews;Richard Angell

  • Proteasome Activation by Small Molecules.

    Yves Leestemaker;Annemieke de Jong;Katharina F. Witting;Renske Penning

  • Studies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers.

    Christoph A. Klaas;Gerd Wagner;Stefan Laufer;Silvio Sosa

  • COX-3: just another COX or the solitary elusive target of paracetamol?

    Jan M Schwab;Hermann J Schluesener;Stefan Laufer

Frequent Co-Authors

Dieter Schollmeyer
Dieter Schollmeyer Johannes Gutenberg University of Mainz
Stefan Knapp
Stefan Knapp Goethe University Frankfurt
Irmgard Merfort
Irmgard Merfort University of Freiburg
Johanne Martel-Pelletier
Johanne Martel-Pelletier University of Montreal
Florian Lang
Florian Lang University of Tübingen
Daniel Rauh
Daniel Rauh TU Dortmund University
Lars Zender
Lars Zender German Cancer Research Center
Jean-Pierre Pelletier
Jean-Pierre Pelletier University of Montreal
Jürgen Bajorath
Jürgen Bajorath University of Bonn
Matthias Schwab
Matthias Schwab University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Stefan Laufer

Trending Scientists

Recently Published Articles